Overview

Malaria Challenge in Healthy Volunteers

Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if sterile, protective immunity to malaria can be induced by malaria parasite exposure limited to the early liver stage of the parasite lifecycle.
Phase:
Phase 1
Details
Lead Sponsor:
Seattle Biomedical Research Institute
Seattle Children's Research Institute (SCRI)
Treatments:
Chloroquine
Chloroquine diphosphate
Primaquine